Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 9, No 2 (2013) A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE Abstract  similar documents
G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi
"... . Rosano, P. Perrone-Filardi «A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors ..."
 
Vol 13, No 2 (2017) PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) Abstract  similar documents
M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov
"... Aim. To assess the clinical and anamnestic characteristics, the prescription rate of angiotensin ..."
 
Vol 5, No 4 (2009) TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS Abstract  similar documents
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky
"... Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow ..."
 
Vol 9, No 4 (2013) ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT Abstract  similar documents
S. Yu. Martsevich
"... ) and angiotensin receptor blockers (ARB) on cardiovascular diseases outcomes are evaluated. Data of the recent meta ..."
 
Vol 16, No 2 (2020) Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine Abstract  similar documents
S. Yu. Martsevich
"... The recent discussion about the dangers of using angiotensin-converting-enzyme (ACE) inhibitors ..."
 
Vol 10, No 6 (2014) IRBESARTAN IN THE CLINICAL PRACTICE Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... (myocardial infarction, stroke, chronic heart and renal failure). Angiotensin receptor blockers are the first ..."
 
Vol 4, No 4 (2008) PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY Abstract  similar documents
S. A. Boytsov, I. P. Kolos
"... Angiotensin II receptor antagonists (ARA) established their position recently duet to new ..."
 
Vol 16, No 6 (2020) Adherence to Clinical Quidelines on Preoperative Assessment and Correction of Cardiovascular Risk in Non-cardiac Surgery Abstract  similar documents
M. D. Nigmatkulova, E. B. Kleymenova, L. P. Yashina, V. A. Otdelenov, S. A. Payushchik, O. D. Konova, D. A. Sychev
"... CoA reductase inhibitors and angiotensin-converting-enzyme (ACE) inhibitors/ angiotensin receptor ..."
 
Vol 2, No 4 (2006) FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS Abstract  similar documents
Yu. M. Lopatin
"... inhibitor and antagonist of angiotensin II receptor are discussed. ..."
 
Vol 3, No 5 (2007) CUMULATIVE CARDIO-VASCULAR RISK IN HYPERTENSIVE PATIENTS: EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS Abstract  similar documents
L. I. Katelnitskaya, L. A. Haisheva, S. E. Glova
"... Цель. Оценить суммарный сердечно-сосудистый (СС) риск и эластические свойства артерий крупного и ..."
 
Vol 4, No 3 (2008) HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA Abstract  similar documents
A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova
"... 2 (D2) and chronic heart failure (CHF) treated with angiotensin converting enzyme (ACE) inhibitors ..."
 
Vol 13, No 3 (2017) ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION Abstract  similar documents
V. I. Podzolkov, M. V. Pisarev
"... An increase in the activity of the renin-angiotensin-aldosterone system is one of the most ..."
 
Vol 9, No 6 (2013) POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK Abstract  similar documents
Z M. Sizova
"... Проанализированы современные возможности блокаторов рецепторов AT1 (БРА), в частности, кандесартана ..."
 
Vol 16, No 3 (2020) On the Quality of Medical Examination: Diagnostic Significance of the Survey Method for Detecting the Probability of Cardio-Cerebral Symptoms Abstract  similar documents
A. M. Kalinina, K. A. Antonov, B. E. Gornyi, I. I. Dubovoj, O. M. Drapkina
"... , у 2,5% впервые, т.е. случаи раннего выявления составили большинство (69,2%). Особенно высокой доля ..."
 
Vol 4, No 3 (2008) ANGIOTENSIN II AND MYOCARDIAL INFARCTION Abstract  similar documents
O. P. Shevchenko, А. О. Shevchenko
"... The role of angiotensin II in pathogenesis of cardiovascular diseases is discussed. Angiotensin II ..."
 
Vol 15, No 2 (2019) Assessment of the Adequacy of Drug Choice in Patients with Acute Myocardial Infarction According to the PROFILE-IM Registry Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov
"... by prescribing beta-blockers (BB), angiotensin converting enzyme inhibitors (ACEI) and statins. This is reflected ..."
 
Vol 6, No 4 (2010) LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... of "cardiovascular continuum". Changes in neurohumoral factors especially activation of the renin-angiotensin ..."
 
Vol 15, No 3 (2019) Hypertension and Headache: the Effect of Antihypertensive Drugs Abstract  similar documents
V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova
"... of hyperactivation of the renin-angiotensin-aldosterone and adrenergic system and endothelial dysfunction ..."
 
Vol 5, No 3 (2009) ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
S. N. Tereshchenko, N. A. Dzhaiani
"... Освещается роль ингибиторов АПФ в современной фармакотерапии больных хронической сердечной ..."
 
Vol 15, No 6 (2019) Outpatient Registry REGION: Prospective Follow-up Data and Outcomes in Patients After Acute Cerebrovascular Accident Abstract  similar documents
M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, K. G. Pereverzeva, E. Yu. Okshina, A. V. Zagrebelnyy, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina
"... ) – HR 0.60 (95%CI 0.42-0.85); angiotensin II receptor blockers (ARB) – HR 0.26 (95%CI 0.13-0.50), beta ..."
 
Vol 3, No 1 (2007) THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION Abstract  similar documents
D. B. Nebieridze, A. S. Safaryan
"... Data of large-scale research that shows comprehensive abilities of an angiotensin converting ..."
 
Vol 16, No 4 (2020) Evaluating Adherence to Medical Therapy in Patients with Chronic Heart Failure: Design and First Results of the COMPLIANCE Study Abstract  similar documents
S. Yu. Martsevich, E. T. Guseynova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, S. V. Blagodatskih
"... included into the study were analyzed. 90% of patients received angiotensin-converting enzyme inhibitors ..."
 
Vol 4, No 5 (2008) INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS Abstract  similar documents
V. V. Fomin
"... and cardiovascular complications are discussed with focus on usage of angiotensin II receptor blockers. ..."
 
Vol 1, No 1 (2005) EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE Abstract  similar documents
Jose Lopez-Sendon, Karl Swedberg, John McMurray, Juan Tamargo, Aldo P. Maggioni, Henry Dargie, Michal Tendera, Finn Waagstein, Jan Kjekshus, Philippe Lechat, Christian Torp-Pedersen
"... Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. ..."
 
Vol 6, No 1 (2010) ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya
"... Aim. To evaluate the cardioprotective effects of ACE inhibitor, ramipril and angiotensin II ..."
 
Vol 7, No 1 (2011) SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
"... A role of angiotensin-converting enzyme (ACE) inhibitors in cardiovascular diseases treatment ..."
 
Vol 5, No 6 (2009) EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) Abstract  similar documents
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko
"... channel blockers, 420 (53,2%) patients – diuretics and 28 (3,5%) patients - angiotensin II receptor ..."
 
Vol 3, No 3 (2007) REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS Abstract  similar documents
M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova
"... of antihypertensive drugs in mono- and combined therapy. Angiotensin converting enzyme (ACE) inhibitors keep important ..."
 
Vol 9, No 2 (2013) ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY Abstract  similar documents
S. Yu. Martsevich
"... Comments to the paper G. Savarese et al. A Meta-Analysis Reporting Effects of Angiotensin ..."
 
Vol 10, No 5 (2014) CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE Abstract  similar documents
S. V. Gatsura, O. A. Gatsura, A. N. Golosova
"... risk and absence of compelling indications. Results. Angiotensin converting enzyme inhibitors (ACEI ..."
 
Vol 16, No 6 (2020) Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries) Abstract  similar documents
M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina
"... ) was associated with the prescription of anticoagulants, angiotensin-converting enzyme (ACE) inhibitors ..."
 
Vol 8, No 6 (2012) SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES Abstract  similar documents
K. A. Gyamdzhyan, M. L. Maksimov
"... -angiotensin-aldosterone system are discussed. Efficacy and safety of two major cardiovascular drug classes ..."
 
Vol 12, No 1 (2016) CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova
"... was 26.1%. We have noted insufficient ACE inhibitors/angiotensin receptor blockers (ARB) and beta ..."
 
Vol 10, No 5 (2014) OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... .01, respectively). Patients treated with ACE inhibitors or angiotensin receptor blockers (ARB) had lower all-cause ..."
 
Vol 3, No 2 (2007) CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS Abstract  similar documents
V. S. Zadionchenko, N. B. Holodkova, O. I. Nesterenko, I. V. Pogonchenkova, A. M. Shchikota, Y. V. Ignatova, I. Y. Malyshev, E. B. Manukhina, S. V. Kruglov, D. A. Pokidyshev, O. A. Zemnina
"... and peripheral hemodynamics and to evaluate how these characteristics are influenced by angiotensin II receptors ..."
 
Vol 6, No 1 (2010) HEMODYNAMIC AND METABOLIC EFFECTS OF NEBIVOLOL IN LOCOMOTIVE CREW STAFF WITH NEWLY DIAGNOSED ARTERIAL HYPERTENSION Abstract  similar documents
I. V. Osipova, O. N. Antropova, E. I. Bravkova, A. G. Zaltsman, T. B. Belousova, T. V. Perevozchikova, I. A. Batanina
"... 20-55 лет с впервые выявленной АГ 1-2-й степени, I-II стадии, умеренного или высокого риска сердечно ..."
 
Vol 6, No 4 (2010) ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? Abstract  similar documents
D. V. Nebieridze, A. S. Safarian
"... ингибиторов АПФ (иАПФ). Широко известны традиционные ниши применения иАПФ — артериальная гипертония, сердечная ..."
 
Vol 14, No 3 (2018) NEW-ONSET ATRIAL FIBRILLATION IN SETTINGS OF ACUTE CORONARY SYNDROME. CURRENT ISSUES Abstract  similar documents
G. S. Galjautdinov1, I. V. Gorelkin, K. R. Ibragimova, R. R. Sadriev
"... Настоящий обзор посвящен теме впервые возникшей фибрилляции предсердий (ФП) в условиях острого ..."
 
Vol 3, No 2 (2007) OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
K. S. Lexina, N. Y. Timofeeva, V. S. Zadionchenko, G. G. Shehian, K. A. Aldushina
"... dysfunction and atherogenesis. There are data that angiotensin converting enzyme inhibitor, zofenopril, has ..."
 
Vol 14, No 6 (2018) Angiotensin Converting Enzyme Inhibitors and the Risk of Lung Cancer – New Scientific Evidences or Another Example of “Pseudo-Evidence” Medicine? Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich
"... The quality of the database analysis that led to the conclusion that angiotensin converting enzyme ..."
 
Vol 2, No 4 (2006) ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
K. Yu. Nikolaev, G. I. Lifshits, A. A. Nikolaeva, I. M. Gicheva
"... Aim. To estimate an effect of enalapril, angiotensin converting enzyme (ACE) inhibitor , on left ..."
 
Vol 13, No 3 (2017) SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION Abstract  similar documents
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
"... risk factors and recommendation on their correction. A tendency to under-prescription of angiotensin ..."
 
Vol 16, No 2 (2020) The Capabilities of Amlodipine/Lisinopril Single-Pill Combination in the Treatment of Newly Diagnosed Arterial Hypertension in a Middle-Aged Patient (Case Report) Abstract  similar documents
A. I. Kochetkov, M. V. Lopukhina, E. A. Kotaeva, A. A. Kirichenko, O. D. Ostroumova
"... , увеличивающих сердечно-сосудистую заболеваемость и смертность во всем мире, в том числе, и в Российской ..."
 
Vol 5, No 6 (2009) ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE Abstract  similar documents
E. A. Ryabikhin, M. E. Mozheiko
"... антигипертензивный препарат, снижающий риск сосудистых катастроф и осложнений АГ у больных высокого сердечно ..."
 
Vol 3, No 1 (2007) CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA Abstract  similar documents
M. V. Melnik, A. M. Shilov, I. R. Kim, O. N. Retivykh, A. A. Saricheva
"... CHF therapy (angiotensin converting enzyme inhibitors, β-blockers, diuretics, cardiac glycosides ..."
 
Vol 13, No 4 (2017) PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY Abstract  similar documents
O. M. Drapkina, D. U. Akasheva
"... and renin-emangiotensin/em-aldosterone, is the basis of modern concepts of the pathogenesis of heart failure ..."
 
Vol 3, No 5 (2007) LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE Abstract  similar documents
N. P. Kutishenko, S. J. Martsevich
"... Data of multicenter clinical trials on assessment of emangiotensin/em converting enzyme inhibitor ..."
 
Vol 15, No 5 (2019) Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis Abstract  similar documents
L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok
"... .001). Patients in group 2 were more likely to receive statins (p0.001), β-blockers (p0.001), emangiotensin/em ..."
 
Vol 9, No 5 (2013) PRIMARY CARE PROBLEMS IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
O. A. Shtegman
"... Цель. Оценить эффективность медицинского обслуживания амбулаторных больных хронической emсердечной/em ..."
 
Vol 14, No 1 (2018) COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman
"... .05). The frequency of the prescriptions of emangiotensin/em II receptor blockers, antagonists of mineralocorticoid ..."
 
Vol 12, No 6 (2016) CHRONIC HEART FAILURE: CLINICAL GUIDELINES AND REAL CLINICAL PRACTICE Abstract  similar documents
E. K. Shavarova, L. A. Babaeva, S. S. Padaryan, N. N. Soseliya, O. I. Lukina, A. S. Milto
"... not receive medical treatment before admission. 34% of patients with HFrEF received ACE inhibitors/emangiotensin/em ..."
 
Vol 13, No 2 (2017) ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE Abstract  similar documents
V. I. Podzolkov, N. A. Dragomiretskaya
"... The importance of renin-emangiotensin/em-aldosterone system in pathogenesis of different clinical ..."
 
Vol 7, No 4 (2011) SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION Abstract  similar documents
S. V. Nedogoda
"... Peculiarities of the treatment with emangiotensin/em II receptor blocker telmisartan are analyzed ..."
 
Vol 16, No 2 (2020) Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries Abstract  similar documents
O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich
"... that these patients were less likely to receive aspirin (p=0.015), dual antiplatelet therapy (p=0.003), emangiotensin/em ..."
 
Vol 3, No 2 (2007) CARDIAC RUPTURE IN MYOCARDIAL INFARCTION: INCIDENCE AND PREDISPOSING FACTORS (15 YEAR FOLLOW-UP) Abstract  similar documents
V. A. Shulman, S. E. Golovenkin, V. V. Radionov, T. M. Parfenova, G. V. Matyushin
"... between women and men. MI therapy more often included betablockers, emangiotensin/em converting enzyme ..."
 
Vol 13, No 3 (2017) BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL Abstract  similar documents
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov
"... retention, and the activation of renin-emangiotensin/em-aldosterone and sympathoadrenal systems. Carvedilol ..."
 
Vol 16, No 5 (2020) Comparative Characteristics of Patients with Cerebral Stroke and Myocardial Infarction in Outpatient Practice: Structure of Comorbidity, Risk Factors, Drug Treatment and Outcomes Abstract  similar documents
A. N. Vorobyev, K. G. Pereverzeva, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, E. Yu. Okshina, O. M. Drapkina
"... antihypertensive therapy for hypertension, as well as emangiotensin/em-converting-enzyme (ACE) inhibitors/emangiotensin/em ..."
 
Vol 6, No 2 (2010) RATIONAL COMBINATIONS IN HYPERTENSION TREATMENT Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... ингибиторов ангиотензин-превращающего фермента (emиАПФ/em) и дигидропиридинового антагониста кальция (АК), на ..."
 
Vol 6, No 3 (2010) BLUMENTHAL SCREENING FOR CARDIOVASCULAR RISK IN ASYMPTOMATIC PATIENTS Abstract  similar documents
J. S. Berger, C. O. Jordan, D. Lloyd-Jones, R.S. Blumenthal
"... emСердечно/em-сосудистые заболевания (ССЗ) — основная причина смертности в западных странах и одна из ..."
 
Vol 3, No 4 (2007) RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION Abstract  similar documents
I. V. Szirov, E. V. Malichenko
"... emAngiotensin/em converting enzyme inhibitors are the first line medicine for the treatment of the most ..."
 
Vol 8, No 2 (2012) TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... Data on emangiotensin/em II receptor blockers, one of the main drug classes used in cardiology ..."
 
Vol 16, No 5 (2020) Effect of Amiodarone, Sotalol and Bisoprolol on Heart Rate Variability in Patients with Atrial Fibrillation Abstract  similar documents
E. P. Popova, S. S. Puzin, O. T. Bogova, S. N. Puzin, D. A. Sychev, V. P. Fisenko
"... emсердечного/em ритма 5-минутных интервалов электрокардиографии. В исследование включены пациенты с emвпервые/em ..."
 
Vol 16, No 5 (2020) The Role of Adherence to Basic Pharmacotherapy of Heart Failure for Prevention of Late Adverse Events in Patients with Coronary Artery Disease and Left Ventricular Dysfunction After Surgical Revascularization of Myocardium Abstract  PDF (Eng)  similar documents
O. A. Yepanchintseva, K. A. Mikhaliev, I. V. Shklianka, O. J. Zharinov, B. M. Todurov
"... . The enrolled sample of patients was characterized by high discharge prescription rate of renin-emangiotensin/em ..."
 
Vol 12, No 3 (2016) GENETIC PREDICTORS OF ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina
"... the development of AF. The study of genes of renin-emangiotensin/em-aldosterone system (RAAS) is especially important ..."
 
Vol 6, No 5 (2010) INFILTRATIVE CARDIOVASCULARDISEASES: CARDIOMYOPATHIES THAT LOOK ALIKE Abstract  similar documents
J.B. Seward, G. Casclang-Verzosa, N. S. Chipigina
"... экспертов ВНОК Статья J. B. Seward, G. Casaclang-Verzosa Infiltrative Cardiovascular Diseases emвпервые/em ..."
 
Vol 8, No 1 (2012) THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE Abstract  similar documents
V. V. Yakusevich, A. Yu. Malygin, S. V. Lychenko, A. S. Petrochenko, A. V. Kabanov
"... , динамику неврологического дефицита и эндотелиальной дисфункции у пациентов с emвпервые/em возникшим ишемическим ..."
 
Vol 14, No 2 (2018) PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
"... Хроническая emсердечная/em недостаточность (ХСН) представляет собой значимую социальную и экономическую ..."
 
Vol 15, No 6 (2019) Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov
"... single-pill combinations is the combination of an emangiotensin/em II receptor blocker and a calcium channel ..."
 
Vol 14, No 5 (2018) Associations of Cardiovascular Risk Factors and Genetic Markers with Development of Arterial Hypertension in the Population of Mountain Shoriya Abstract  similar documents
T. A. Mulerova, S. A. Maksimov, M. Yu. Ogarkov, O. V. Gruzdeva, A. V. Ponasenko, V. N. Maksimov, M. I. Voyevoda, E. S. Filimonov, G. V. Artamonova
"... the proteins of the main components of neurophysiological systems (renin-emangiotensin/em-aldosterone, sympathetic ..."
 
Vol 16, No 5 (2020) Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register Abstract  similar documents
I. S. Skopets, N. N. Vezikova, A. V. Malafeev, A. N. Malygin, V. A. Litvinova
"... .8% – clopidogrel, 91.1% – anticoagulants, 91.6% – beta-blockers, 95.6% – statins, 94.2% – emangiotensin/em-converting ..."
 
Vol 6, No 3 (2010) THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, Ju. N. Rodionova, E. K. Panferova
"... Aim. To study the correlation of the renin-emangiotensin/em-aldosterone system (RAAS) activity ..."
 
Vol 5, No 2 (2009) CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL Abstract  similar documents
D. A. Napalkov, E. N. Golovenko
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... .23. Patients were randomized into 4 treatment groups: Group A1 (emangiotensin/em converting enzyme (ACE) inhibitors ..."
 
Vol 6, No 5 (2010) THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? Abstract  similar documents
S. Yu. Martsevich
"... The main trails proven emangiotensin/em converting enzyme (ACE) inhibitor effects on the life prognosis ..."
 
Vol 11, No 6 (2015) Cardiometabolic properties of telmisartan: new perspectives for use Abstract  similar documents
O. M. Drapkina, E. I. Fomicheva
 
Vol 3, No 3 (2007) ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... Data of studies devoted to application of emangiotensin/em converting enzyme (ACE) inhibitors in acute ..."
 
Vol 3, No 5 (2007) EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION Abstract  similar documents
L. N. Chikhireva, V. I. Malahov, E. S. Bykova, S. F. Sokolov
"... Aim. To evaluate effects of emangiotensin/em converting enzyme inhibitor spirapril on efficacy ..."
 
Vol 10, No 3 (2014) RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING Abstract  similar documents
V. S. Pykhtina, I. D. Strazhesko, M. V. Agaltsov, O. N. Tkacheva
"... is paid to the activation of the renin-emangiotensin/em-aldosterone system as a source of chronic inflammation ..."
 
Vol 16, No 1 (2020) An Attempt to Accord the Quality of Therapy of Stable Coronary Heart Disease Patients with Current Clinical Guidelines (ALIGN study): Design and the First Results Abstract  similar documents
S. Yu. Martsevich, E. D. Zharkova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, A. V. Zagrebelnyy
"... by 53 (74.6%) patients, but only 21 (29.6%) achieved the target values of LDL cholesterol. emAngiotensin/em ..."
 
Vol 13, No 4 (2017) CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE Abstract  similar documents
O. D. Ostroumova, E. A. Smolyarchuk, O. V. Bondarec, E. E. Paleeva
"... The features of the pharmacokinetics of the emangiotensin/em II receptor blocker telmisartan ..."
 
Vol 15, No 4 (2019) Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov
"... with single-pill combinations (SPCs) in majority patients with AH. Combination of the emangiotensin/em II receptor ..."
 
Vol 14, No 3 (2018) COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU Abstract  similar documents
S. V. Povetkin, O. V. Levashova, V. I. Ghicavii, N. G. Batchinschi, L. A. Pjdgurschi, L. M. Turca
"... ) inhibitors, then diuretics. The shares of calcium channels blockers (CCB) and emangiotensin/em II receptors ..."
 
Vol 15, No 4 (2019) Antihypertensive Drug Utilization in Two Districts of Northern Cyprus Abstract  PDF (Eng)  similar documents
M. Tamirci, R. Demirdamar
"... .1%), emangiotensin/em receptor blockers (ARBs) (22.1%), calcium channel blockers (20.4%), emangiotensin/em converting enzyme ..."
 
Vol 9, No 4 (2013) REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy
"... с высоким риском emсердечно/em-сосудистых осложнений. Материал и методы. За период с 1 мая по 31 декабря ..."
 
Vol 16, No 4 (2020) The Peculiarity of Process and Treatment of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus Abstract  similar documents
T. Yu. Demidova, O. A. Kislyak
"... группе высокого и очень высокого риска развития emсердечно/em-сосудистых осложнений и хронической болезни ..."
 
Vol 9, No 2 (2013) MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina
"... Цель. Оценить качество коррекции нарушений липидного обмена у больных emсердечно/em-сосудистыми ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... increase up to 14.7% in prescription rate of emangiotensin/em receptor blockers was revealed ..."
 
Vol 8, No 1 (2012) EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK Abstract  similar documents
I. M. Sokolov, N. A. Zheleznyakova
"... clinical trials. The triple combination of calcium antagonist, emangiotensin/em II receptor blocker and thiazide ..."
 
Vol 10, No 3 (2014) THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) Abstract  similar documents
M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
"... receiving b-blockers, 35.3% - renin-emangiotensin/em-aldosterone system (RAAS) inhibitors, 15.7% - antiplatelet ..."
 
Vol 8, No 1 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... inhibit renin–emangiotensin/em–aldosterone system (RAAS). Novel targets for antihypertensive therapy could ..."
 
Vol 8, No 2 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... inhibit renin–emangiotensin/em–aldosterone system (RAAS). Novel targets for antihypertensive therapy could ..."
 
Vol 10, No 2 (2014) ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION Abstract  similar documents
N. A. Dzhaiani
"... lercanidipine and emangiotensin/em-converting enzyme inhibitor enalapril. ..."
 
Vol 9, No 2 (2013) FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE Abstract  similar documents
O. D. Ostroumova, I. I. Kopchenov
"... for different clinical situations are presented. Advantages and indications for combination of an emangiotensin/em ..."
 
Vol 5, No 3 (2009) FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY Abstract  similar documents
O. G. Zaylobidinov, Yu. N. Ziyaev, N. K. Kamilova, A. S. Khalilov, B. F. Mukhamedova
 
Vol 4, No 1 (2008) EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY Abstract  similar documents
S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza
"... Aim. To compare the effects of long-term therapy with emangiotensin/em-II receptor antagonist losartan ..."
 
Vol 3, No 2 (2007) RESULTS OF OUTPATIENT PROGRAM ON EFFECTIVE THERAPY OF REFRACTORY ARTERIAL HYPERTENSION Abstract  similar documents
M. M. Batyushin, I. V. Derevyankina, M. Z. Gasanov, O. V. Akopova, K. I. Babiyan, Y. N. Boychenko, N. V. Vasilchenko, T. A. Gabysyan, S. Ch. Gayboryan, I. S. Golovatenko, N. M. Demkova, D. O. Dmitriev, E. V. Kirtava, O. L. Kotyankova, G. V. Ludanova, S. A. Lyashenko, A. E. Malichina, O. I. Poroshenko, A. V. Svechnikova, I. Y. Sidorov, E. V. Solyannikova, I. D. Tascheyan, E. A. Heygetyan, S. E. Evruyan
"... to reach target level of blood pressure (BP). This therapy lasted 24 weeks and included emangiotensin/em ..."
 
Vol 3, No 3 (2007) STRESS: WHAT WE ACTUALLY KNOW ABOUT THIS RISK FACTOR? Abstract  similar documents
R. G. Oganov, G. V. Pogosova
"... стресса с заболеваемостью и смертностью от emсердечно/em-сосудистых заболеваний. Представлены разновидности ..."
 
Vol 2, No 2 (2006) HEART RATE VARIABILITY IN ASSESSMENT OF CLINICAL STATUS, FUNCTIONAL CONDITIONS AND PROGNOSIS IN HEART FAILURE Abstract  similar documents
Y. A. Vasyuk, E. Y. Shupenina, E. N. Yuschuk, M. K. Serova
"... Представлена методика оценки вариабельности emсердечного/em ритма у здоровых людей и больных ..."
 
Vol 16, No 2 (2020) LIS-3 Acute Coronary Syndrome Registry: Changes in Clinical and Demographic Characteristics and Tactics of Prehospital and Hospital Treatment of Surviving Patients After Acute Coronary Syndrome Over a 4-Year Period Abstract  similar documents
S. Yu. Martsevich, A. V. Zagrebelnyy, N. P. Zolotareva, N. P. Kutishenko, Yu. V. Lukina, M. L. Ginzburg, D. A. Startsev, S. V. Blagodatskikh
"... of use of acetylsalicylic acid, clopidogrel, statins, beta-blockers, ACE inhibitors, emangiotensin/em II ..."
 
1 - 100 of 818 Items 1 2 3 4 5 6 7 8 9 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)